These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37747407)

  • 21. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.
    Taddei PJ; Mirkovic D; Fontenot JD; Giebeler A; Zheng Y; Kornguth D; Mohan R; Newhauser WD
    Phys Med Biol; 2009 Apr; 54(8):2259-75. PubMed ID: 19305045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
    Moteabbed M; Yock TI; Paganetti H
    Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
    Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
    Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.
    Tamura M; Sakurai H; Mizumoto M; Kamizawa S; Murayama S; Yamashita H; Takao S; Suzuki R; Shirato H; Ito YM
    J Radiat Res; 2017 May; 58(3):363-371. PubMed ID: 27789564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term risks of secondary cancer for various whole and partial breast irradiation techniques.
    Hoekstra N; Fleury E; Merino Lara TR; van der Baan P; Bahnerth A; Struik G; Hoogeman M; Pignol JP
    Radiother Oncol; 2018 Sep; 128(3):428-433. PubMed ID: 29914648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling recurrence and second cancer risks induced by proton therapy.
    Manem VSK; Dhawan A
    Math Med Biol; 2018 Sep; 35(3):347-361. PubMed ID: 29106564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.
    Nguyen J; Moteabbed M; Paganetti H
    Med Phys; 2015 Jan; 42(1):81-9. PubMed ID: 25563249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer.
    Santos AMC; Kotsanis A; Cunningham L; Penfold SN
    Acta Oncol; 2021 Mar; 60(3):300-304. PubMed ID: 33345660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation based on Monte Carlo simulation of lifetime attributable risk of cancer after neck X-ray radiography.
    Seo D; Han S; Kim KH; Kim J; Park K; Lim H; Kim J
    Radiol Med; 2015 Nov; 120(11):1043-9. PubMed ID: 25920438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative Effective Dose and Cancer Risk of Pediatric Population in Repetitive Whole-Body Scan Using Dual-Energy X-Ray Absorptiometry.
    Law M; Ma WK; Chan E; Mui C; Ma V; Ho WY; Yip L; Lam W
    J Clin Densitom; 2019; 22(1):52-58. PubMed ID: 29111198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of lifetime attributable risks (LARs) of cancer associated with abdominopelvic radiotherapy treatment planning computed tomography (CT) simulations.
    Bagherzadeh S; Jabbari N; Khalkhali HR
    Int J Radiat Biol; 2018 May; 94(5):454-461. PubMed ID: 29528791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling the influence of radiosensitivity on development of second primary cancer in out-of-field organs following proton therapy for paediatric cranial cancer.
    Dell'Oro M; Wilson P; Short M; Peukert D; Bezak E
    Br J Radiol; 2023 Oct; 96(1150):20230161. PubMed ID: 37660473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
    Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
    Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging doses and secondary cancer risk from kilovoltage cone-beam CT in radiation therapy.
    Kim DW; Chung WK; Yoon M
    Health Phys; 2013 May; 104(5):499-503. PubMed ID: 23532078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case.
    Arruda GV; Weber RRDS; Bruno AC; Pavoni JF
    Int J Radiat Biol; 2021; 97(2):120-125. PubMed ID: 33164596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the RayStation Monte Carlo dose calculation algorithm using a realistic lung phantom.
    Schreuder AN; Bridges DS; Rigsby L; Blakey M; Janson M; Hedrick SG; Wilkinson JB
    J Appl Clin Med Phys; 2019 Dec; 20(12):127-137. PubMed ID: 31763759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.